Real-life experience with nivolumab and pembrolizumab in patients(pts) with advanced non-small cell lung cancer (NSCLC): Efficacy and safety analysis at the University Hospital Zurich

被引：0
|
作者：
Sanoyan, D. Akhoundova [1 ]
Siebenhuner, A. [1 ]
Delaloye, R. [1 ]
Bankel, L. [1 ]
Paulino, T. D. L. [2 ]
Curioni, A. [1 ]
机构：
[1] Univ Hosp Zurich, Med Oncol, Zurich, Switzerland
[2] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
23P
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [21] Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer
    Morgensztern, Daniel
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3713 - 3717
  • [22] Nivolumab for Non-Small Cell Lung Cancer (NSCLC): An Economic Model for Risk Sharing Based on Real-Life Data
    Dudnik, Elizabeth
    Goldstein, Daniel
    Roisman, Laila
    Hammerman, Ariel
    Greenberg-Dotan, Sari
    Bar, Jair
    Moskovitz, Mor
    Daher, Sameh
    Shamai, Sivan
    Hanovich, Ekaterina
    Shechtman, Yelena
    Abu-Amna, Mahmoud
    Zer, Alona
    Wollner, Mira
    Merimsky, Ofer
    Cyjon, Arnold
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1432 - S1433
  • [23] Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer
    Hida, Toyoaki
    Nishio, Makoto
    Nogami, Naoyuki
    Ohe, Yuichiro
    Nokihara, Hiroshi
    Sakai, Hiroshi
    Satouchi, Miyako
    Nakagawa, Kazuhiko
    Takenoyama, Mitsuhiro
    Isobe, Hiroshi
    Fujita, Shiro
    Tanaka, Hiroshi
    Minato, Koichi
    Takahashi, Toshiaki
    Maemondo, Makoto
    Takeda, Koji
    Saka, Hideo
    Goto, Koichi
    Atagi, Shinji
    Hirashima, Tomonori
    Sumiyoshi, Naoki
    Tamura, Tomohide
    CANCER SCIENCE, 2017, 108 (05) : 1000 - 1006
  • [24] Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC).
    Drilon, Alexander E.
    Camidge, D. Ross
    Ou, Sai-Hong Ignatius
    Clark, Jeffrey William
    Socinski, Mark A.
    Weiss, Jared
    Riely, Gregory J.
    Winter, Maria
    Wang, Sherry C.
    Monti, Katherine
    Wilner, Keith D.
    Paik, Paul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study
    Perol, M.
    Dixmier, A.
    Barlesi, F.
    Debieuvre, D.
    Raspaud, C.
    Auliac, J. B.
    Benoit, N.
    Bombaron, P.
    Moro-Sibilot, D.
    Asselain, B.
    Cotte, F-E.
    Lamoureux, P.
    Karam, N.
    Ozan, N.
    Calvet, C.
    Bryan, B.
    Allan, V.
    Valette, C. Audigier
    ANNALS OF ONCOLOGY, 2019, 30 : 46 - 46
  • [26] Safety of Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) in the Real-Life Setting: A Single-Institution Experience from Argentina
    Bluthgen, M.
    Tamburelli, M.
    Calderon, C.
    Castillo, J.
    Bas, C.
    Abuin, G. Gomez
    Sena, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S536 - S536
  • [27] Real-life experience of ceritinib in crizotinib-pretreated ALK(+) advanced non-small cell lung cancer patients
    Cadranel, Jacques
    Cortot, Alexis B.
    Lena, Herve
    Mennecier, Bertrand
    Do, Pascal
    Dansin, Eric
    Mazieres, Julien
    Chouaid, Christos
    Perol, Maurice
    Barlesi, Fabrice
    Robinet, Gilles
    Friard, Sylvie
    Thiberville, Luc
    Audigier-Valette, Clarisse
    Vergnenegre, Alain
    Westeel, Virginie
    Slimane, Khemaies
    Buturuga, Alexandru
    Moro-Sibilot, Denis
    Besse, Benjamin
    ERJ OPEN RESEARCH, 2018, 4 (01)
  • [28] Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC)
    Gettinger, S. N.
    Horn, L.
    Ramalingam, S. S.
    Spigel, D. R.
    Paz-Ares, L.
    Paik, P.
    Reck, M.
    Reckamp, K.
    Mazieres, J.
    Stinchcombe, T.
    Lynch, M.
    Brahmer, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S631 - S631
  • [29] Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology
    Sankawa, Yuri
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (03) : 149 - 149
  • [30] The safety of nivolumab for the treatment of advanced non-small cell lung cancer
    Metro, Giulio
    Ricciuti, Biagio
    Brambilla, Marta
    Baglivo, Sara
    Soli, Irene
    Minenza, Elisa
    Leonardi, Giulia Costanza
    D'arpino, Alessandro
    Colabrese, Daniela
    Tazza, Marco
    Zicari, Daniela
    Minotti, Vincenzo
    Chiari, Rita
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) : 101 - 109
12345